StockDrifts LogoStockDrifts

Labgenomics 084650

Company
랩지노믹스Labgenomics
Insiders
3
Buys
6
Total Value
₩3.2B ($2.2M)
Avg Return
-9.28%
Last Filing
2026-07-09

Labgenomics (084650) has 6 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩3.2B ($2.2M) in reported transaction value. The earliest filing StockDrifts holds for Labgenomics is dated 2023-06-29; the most recent is 2026-07-09. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -9.28%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-09BUYMarket Buy
루하갈락티코스
Ruha Galacticos
-970.1K₩819-12.2%₩820M ($569K)
2026-07-08BUYMarket Buy
루하갈락티코스
Ruha Galacticos
-270.0K₩693+3.8%₩180M ($125K)
2026-06-10BUYMarket Buy
루하갈락티코스
Ruha Galacticos
-679.5K₩1,228-28.5%₩834M ($579K)
2026-06-09BUYMarket Buy
루하갈락티코스
Ruha Galacticos
-432.7K₩1,157-24.1%₩501M ($348K)
2026-06-08BUYMarket Buy
루하갈락티코스
Ruha Galacticos
-781.7K₩890-1.4%₩696M ($483K)
2026-05-20SELLMarket Sell
오미진
Oh Mi-jin
Managing Director-29.0K₩1,370+23.4%₩40M ($28K)
2026-05-18SELL전환권등소멸
루하갈락티코스
Ruha Galacticos
--7.3M₩1,271+30.9%₩9.3B ($6.5M)
2024-06-18BUYMarket Buy
이종훈
Jong-Hoon Lee
CEO42.0K₩2,190-25.9%₩92M ($64K)
2024-04-18BUY행사가액조정
루하갈락티코스
Ruha Galacticos
-4.3M₩2,680-39.4%₩11.5B ($8.0M)
2024-01-18BUY행사가액조정
루하갈락티코스
Ruha Galacticos
-90.3K₩3,610-55.0%₩326M ($226K)
2023-08-29BUY기타
권순길
Kwon Soon-gil
Managing Director1.3K₩5,290-69.3%₩7M ($5K)
2023-08-08BUY신규선임
성광진
Seong Gwang-jin
Managing Director14.1K₩4,780-66.0%₩67M ($47K)
2023-06-29BUY신규선임
성광진
Seong Gwang-jin
Managing Director14.1K₩3,540-54.1%₩50M ($35K)

Frequently asked questions

Who has been buying Labgenomics stock?
3 distinct insiders have filed 6 disclosed insider purchases in Labgenomics (084650), most recently on 2026-07-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Labgenomics have?
Labgenomics has 6 buy-side and 1 sell-side disclosures on record, covering ₩3.2B ($2.2M) in total reported value, spanning 2023-06-29 to 2026-07-09.
Where does StockDrifts get Labgenomics insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Labgenomics. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.